Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis
Launched by UNIVERSITY HOSPITAL, BREST · Dec 16, 2020
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether wearing special Boarding Ring glasses can help patients with vestibular neuritis recover more quickly from their symptoms. Vestibular neuritis is a condition that causes severe dizziness, a spinning sensation, and sometimes nausea, but it does not affect hearing. The study aims to see if these glasses can assist the body in adjusting and compensating for the balance issues caused by the condition.
To participate in this trial, you need to be an adult aged 65 to 74 who is experiencing continuous dizziness and has certain eye movements that indicate vestibular neuritis. You should not have a history of other types of vertigo, hearing loss, or certain eye movement disorders. If you join the study, you can expect to wear the glasses during the trial period and be monitored for changes in your symptoms. This research could be important for finding better treatments for dizziness related to vestibular neuritis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult patients,
- • patient with vestibular neuritis defined by appearance of continuous rotating vertigo with nausea
- • patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear
- • patient with a postural deviation towards the affected ear;
- • vestibular hyporeflexia measured at the caloric tests greater than 25%
- • patient who has given free, enlighten and written consent
- Exclusion Criteria:
- • patient with a history of vertigo of vestibular origin or with vertigo developing for more than 4 days
- • patient with associated hearing loss or tinnitus
- • patient with an motor ocular abnormality of central origin
- • patient refusal or inability to consent
About University Hospital, Brest
The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brest, , France
Quimper, , France
Morlaix, , France
Patients applied
Trial Officials
Jean-Christophe LECLERE, Dr
Principal Investigator
University Hospital, Brest
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials